The PSMA PET radiopharmaceutical 64Cu-SAR-bisPSMA, which previously garnered two FDA fast track designations, more than doubled the detection of PCa lesions in comparison to 68Ga-PSMA-11 in the phase II Co-PSMA trial.
|Articles|October 2, 2009
With meeting approaching, RSNA responds to H1N1 flu risk
Author(s)James Brice
With no major health organization advising delay, the Radiological Society of North America is moving forward with its 2009 meeting, despite evidence suggesting the week-long event will be held in the midst of an H1N1 flu epidemic.
Advertisement
Array
Advertisement
Related to this article
The mobile X-Ray unit DR 100s Pro reportedly offers an array of attributes to facilitate workflow efficiencies and quality imaging.
In comparison to the RECIST 1.1 criteria, use of the mpMRI-based NacBI-RADS system for evaluating response to neoadjuvant chemotherapy (NAC) for breast cancer offered an 8 percent higher sensitivity and over 26 percent higher specificity.
A high glandular tissue component on pre-op breast ultrasound may significantly elevate the risk of recurrence for ipsilateral or contralateral breast cancer, according to a newly published study.
Effective January 1, 2027, use of the QTscan in outpatient diagnostic exams will be reimbursable with the CPT code 1079T.
In a recent interview, Carolynn DeBenedectis, MD, discussed the utility of AI-enabled slab reconstruction for interpretation of digital breast tomosynthesis (DBT) and new research showing a 13 percent reduction in reading time.
Keeping defensiveness and ego at bay is just one of the attributes of those who consistently embrace learning from others over the course of one’s life.
Catch up on the top radiology content of the past week.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Agfa Radiology to Introduce AI-Powered DR 100s Pro X-Ray Platform at RSNA
2
CMS Reverses Decision and Issues New Outpatient CPT Code for Ultrasound-Based QTscan
3
Breast Ultrasound Study: High Glandular Tissue Component May Double Recurrence Risk for Invasive Breast Cancer
4
Could an Emerging NacBI-RADS System for mpMRI Bolster Assessment of NAC Response?
5